ClinicalTrials.gov record
Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes
ClinicalTrials.gov ID: NCT00399711
Public ClinicalTrials.gov record NCT00399711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Repaglinide and Metformin Combination Tablet (NN4440) in a TID Regimen Compared to a BID Regimen and BID Avandamet in Subjects With Type 2 Diabetes: A Twenty-Six Week, Open-Label, Multicenter, Randomized, Parallel Group Trial to Investigate Efficacy and Safety
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in the United States of America (USA). This trial compares the changes in HbA1c after 26 weeks of repaglinide and metformin fixed dose combination tablet given as twice daily versus three times daily regimens or versus twice daily rosiglitazone and metformin fixed dose combination tablet in subjects with type 2 diabetes currently on monotherapy.
Study identification
- NCT ID
- NCT00399711
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 560 participants
Conditions and interventions
Conditions
Interventions
- repaglinide and metformin combination tablet Drug
- rosiglitazone and metformin combination tablet Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2006
- Primary completion
- Oct 31, 2007
- Completion
- Oct 31, 2007
- Last update posted
- Feb 9, 2017
2006 – 2007
United States locations
- U.S. sites
- 102
- U.S. states
- 35
- U.S. cities
- 93
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Vestavia Hills | Alabama | 35209 | — |
| Novo Nordisk Investigational Site | Glendale | Arizona | 85306 | — |
| Novo Nordisk Investigational Site | Mesa | Arizona | 85206 | — |
| Novo Nordisk Investigational Site | Jonesboro | Arkansas | 72401 | — |
| Novo Nordisk Investigational Site | Chula Vista | California | 91911 | — |
| Novo Nordisk Investigational Site | Long Beach | California | 90807 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90057 | — |
| Novo Nordisk Investigational Site | Poway | California | 92064 | — |
| Novo Nordisk Investigational Site | Redlands | California | 92374 | — |
| Novo Nordisk Investigational Site | Sacramento | California | 95825 | — |
| Novo Nordisk Investigational Site | San Diego | California | 92121 | — |
| Novo Nordisk Investigational Site | San Diego | California | 92128 | — |
| Novo Nordisk Investigational Site | San Mateo | California | 94401 | — |
| Novo Nordisk Investigational Site | Spring Valley | California | 91978 | — |
| Novo Nordisk Investigational Site | Colorado Springs | Colorado | 80904 | — |
| Novo Nordisk Investigational Site | Hamden | Connecticut | 06518 | — |
| Novo Nordisk Investigational Site | Stamford | Connecticut | 06905 | — |
| Novo Nordisk Investigational Site | Aventura | Florida | 33180 | — |
| Novo Nordisk Investigational Site | Clearwater | Florida | 33765 | — |
| Novo Nordisk Investigational Site | Daytona Beach | Florida | 32117 | — |
| Novo Nordisk Investigational Site | Inverness | Florida | 34452 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32116 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32216 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32259 | — |
| Novo Nordisk Investigational Site | Longwood | Florida | 32779 | — |
| Novo Nordisk Investigational Site | Ocala | Florida | 34471 | — |
| Novo Nordisk Investigational Site | Orlando | Florida | 32804 | — |
| Novo Nordisk Investigational Site | Plantation | Florida | 33324 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33603 | — |
| Novo Nordisk Investigational Site | West Palm Beach | Florida | 33401 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30318 | — |
| Novo Nordisk Investigational Site | Columbus | Georgia | 31904 | — |
| Novo Nordisk Investigational Site | Marietta | Georgia | 30066 | — |
| Novo Nordisk Investigational Site | Honolulu | Hawaii | 96814 | — |
| Novo Nordisk Investigational Site | Nampa | Idaho | 83687 | — |
| Novo Nordisk Investigational Site | Arlington Heights | Illinois | 60004 | — |
| Novo Nordisk Investigational Site | Aurora | Illinois | 60504 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60607 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60611 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60616 | — |
| Novo Nordisk Investigational Site | Flossmoor | Illinois | 60422 | — |
| Novo Nordisk Investigational Site | Naperville | Illinois | 60564 | — |
| Novo Nordisk Investigational Site | Oak Brook | Illinois | 60523 | — |
| Novo Nordisk Investigational Site | Springfield | Illinois | 62711 | — |
| Novo Nordisk Investigational Site | Vernon Hills | Illinois | 60061 | — |
| Novo Nordisk Investigational Site | Indianapolis | Indiana | 46250 | — |
| Novo Nordisk Investigational Site | Des Moines | Iowa | 50314 | — |
| Novo Nordisk Investigational Site | Shawnee Mission | Kansas | 66204 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Erlanger | Kentucky | 41018 | — |
| Novo Nordisk Investigational Site | Louisville | Kentucky | 40213 | — |
| Novo Nordisk Investigational Site | Bossier City | Louisiana | 71111 | — |
| Novo Nordisk Investigational Site | Baltimore | Maryland | 21209 | — |
| Novo Nordisk Investigational Site | Hyattsville | Maryland | 20782 | — |
| Novo Nordisk Investigational Site | Ann Arbor | Michigan | 48106 | — |
| Novo Nordisk Investigational Site | Flint | Michigan | 48504 | — |
| Novo Nordisk Investigational Site | Oak Park | Michigan | 48237 | — |
| Novo Nordisk Investigational Site | Troy | Michigan | 48098 | — |
| Novo Nordisk Investigational Site | Kansas City | Missouri | 64111 | — |
| Novo Nordisk Investigational Site | Omaha | Nebraska | 68114 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89102 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89123 | — |
| Novo Nordisk Investigational Site | Berlin | New Jersey | 08009 | — |
| Novo Nordisk Investigational Site | Jersey City | New Jersey | 07306 | — |
| Novo Nordisk Investigational Site | Warren Township | New Jersey | 07059 | — |
| Novo Nordisk Investigational Site | Rochester | New York | 14609 | — |
| Novo Nordisk Investigational Site | West Seneca | New York | 14224 | — |
| Novo Nordisk Investigational Site | Asheville | North Carolina | 28803 | — |
| Novo Nordisk Investigational Site | Greenville | North Carolina | 27834 | — |
| Novo Nordisk Investigational Site | Raleigh | North Carolina | 27609 | — |
| Novo Nordisk Investigational Site | Salisbury | North Carolina | 28144 | — |
| Novo Nordisk Investigational Site | Wilmington | North Carolina | 28401 | — |
| Novo Nordisk Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45245 | — |
| Novo Nordisk Investigational Site | Franklin | Ohio | 45005 | — |
| Novo Nordisk Investigational Site | Tulsa | Oklahoma | 74104 | — |
| Novo Nordisk Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Novo Nordisk Investigational Site | Portland | Oregon | 97220 | — |
| Novo Nordisk Investigational Site | Norristown | Pennsylvania | 19401 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19152 | — |
| Novo Nordisk Investigational Site | Springfield | Pennsylvania | 19064-2527 | — |
| Novo Nordisk Investigational Site | Cranston | Rhode Island | 02920 | — |
| Novo Nordisk Investigational Site | East Providence | Rhode Island | 02914 | — |
| Novo Nordisk Investigational Site | Greer | South Carolina | 29651 | — |
| Novo Nordisk Investigational Site | Mt. Pleasant | South Carolina | 29464 | — |
| Novo Nordisk Investigational Site | Simpsonville | South Carolina | 29681-1538 | — |
| Novo Nordisk Investigational Site | Kingsport | Tennessee | 37660 | — |
| Novo Nordisk Investigational Site | Knoxville | Tennessee | 37920 | — |
| Novo Nordisk Investigational Site | Corpus Christi | Texas | 78412 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75224 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75390-8858 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77024 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77030 | — |
| Novo Nordisk Investigational Site | Midland | Texas | 79707 | — |
| Novo Nordisk Investigational Site | Plano | Texas | 75093 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | — |
| Novo Nordisk Investigational Site | St. George | Utah | 84790 | — |
| Novo Nordisk Investigational Site | Henrico | Virginia | 23233 | — |
| Novo Nordisk Investigational Site | Lebanon | Virginia | 24266 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23229 | — |
| Novo Nordisk Investigational Site | Virginia Beach | Virginia | 23454 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00399711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2017 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00399711 live on ClinicalTrials.gov.